HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James Wild Selected Research

EPI2010

1/2003Clinical potential of respirable antisense oligonucleotides (RASONs) in asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James Wild Research Topics

Disease

5Opioid-Induced Constipation
01/2022 - 01/2017
3Pain (Aches)
01/2022 - 10/2019
3Cancer Pain
01/2021 - 01/2017
2Constipation
01/2022 - 01/2021
2Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2020 - 01/2017
1Chronic Pain
01/2022
1Low Back Pain (Lumbago)
11/2020
1Inflammation (Inflammations)
01/2003
1Asthma (Bronchial Asthma)
01/2003

Drug/Important Bio-Agent (IBA)

5Opioid Analgesics (Opioids)IBA
01/2022 - 01/2017
5naldemedineIBA
01/2022 - 01/2017
1A 7 (A-7)IBA
01/2021
1mu Opioid Receptors (mu Opioid Receptor)IBA
11/2020
1NKTR-181IBA
11/2020
1Narcotic Antagonists (Opioid Antagonists)IBA
01/2017
1Morphine (MS Contin)FDA LinkGeneric
01/2017
1Adenosine (Adenocard)FDA LinkGeneric
01/2003
1EPI2010IBA
01/2003
1Antisense OligonucleotidesIBA
01/2003

Therapy/Procedure

2Therapeutics
01/2020 - 10/2019